Clinical Trials Logo

Pain clinical trials

View clinical trials related to Pain.

Filter by:

NCT ID: NCT00200590 Terminated - Pain Clinical Trials

Analgesic Strategies in Newborns Receiving Prostaglandin Therapy

Start date: December 2003
Phase: N/A
Study type: Interventional

This is a randomised trial comparing the efficacy of 3 different analgesic strategies in newborns on prostaglandin for ductus dependent congenital heart disease.

NCT ID: NCT00187135 Terminated - Pain Clinical Trials

Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration

Start date: March 2002
Phase: Phase 3
Study type: Interventional

St. Jude Children's Research Hospital is studying the best ways to prevent pain during and after procedures such as bone marrow aspiration and lumbar puncture with intrathecal (in the spinal fluid) chemotherapy. Researchers will study the effectiveness of combining anesthetics (medicines that help people sleep) and analgesics (medicines that relieve pain). Researchers believe that a combination of fentanyl (analgesic) and propofol (anesthetic), along with applying the skin-numbing-cream EMLA or L.M.X4™ on the area where the procedure is performed, will provide better pain control. Each patient enrolled on this study will have three different anesthetic combinations for three different procedures, in order to determine which combination worked best for each child.

NCT ID: NCT00161694 Terminated - Pain Clinical Trials

Use of Sucrose to Relieve Pain During Eye Exams in Infants

Start date: July 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to see if an oral sucrose solution can comfort premature infants during their necessary eye exams. The investigators believe that the use of this solution prior to the eye exams will lead to a decrease in pain as measured by a rise in heart rate and a fall in oxygen saturation. In addition this will lead to a decrease in events in the 12 hours following examination. Events include episodes when the infants temporarily stop breathing, have a drop in their heart rates, or have a drop in their oxygen levels.

NCT ID: NCT00159640 Terminated - Pain Clinical Trials

Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia

Start date: February 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effectiveness of PD-217,014 in the treatment of chronic pain following a shingles infection.

NCT ID: NCT00140933 Terminated - Pain Clinical Trials

A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome

Start date: April 2003
Phase: Phase 3
Study type: Interventional

Comparing the short-term efficacy of rofecoxib versus placebo. Patients receive rofecoxib or placebo or diclofenac and fill out a patient diary on daytime pain severity during daily activities, night pain severity, and acetaminophen/paracetamol intake.

NCT ID: NCT00140920 Terminated - Pain Clinical Trials

A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)

Start date: May 25, 2004
Phase: Phase 4
Study type: Interventional

A study to compare pre-operative administration of rofecoxib versus post-operative administration of diclofenac or rofecoxib, respectively, in the treatment of post-operative pain after total knee joint replacement in patients with osteoarthritis of the knee.

NCT ID: NCT00126789 Terminated - Pain Clinical Trials

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

Start date: August 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of the matrix fentanyl patch ZR-02-01 in providing relief of cancer pain.

NCT ID: NCT00126763 Terminated - Pain Clinical Trials

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

Start date: July 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of the matrix fentanyl patch ZR-02-01 in providing relief of non-malignant chronic pain.

NCT ID: NCT00125801 Terminated - Pain Clinical Trials

The Pain Pen for Breakthrough Cancer Pain

Start date: August 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to see whether injection of hydromorphone through a subcutaneous injection device is more effective in treating breakthrough cancer pain than oral morphine.

NCT ID: NCT00101621 Terminated - Pain Clinical Trials

Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain

Start date: August 2004
Phase: Phase 2
Study type: Interventional

M40403 was found to be effective in reducing pain in animal models and in clinical studies of subjects who were experiencing pain after dental surgery. The proposed study is designed to investigate the efficacy and safety of M40403 when co-administered with an opioid in subjects with pain due to cancer.